Article: Nicotinamide Riboside Supplementation Increases NAD+ Levels in Humans: Clinical Findings

Jul 5, 2019 Clinical Pharmacokinetic/Safety

Nicotinamide Riboside Supplementation Increases NAD+ Levels in Humans: Clinical Findings

Objectives

To evaluate the safety and efficiacy of NR supplementation in overweight, but otherwise healthy men and women.

Journal

Scientific Reports

Key Outcomes

NR supplementation significantly and dose-dependently increased whole blood NAD+ levels by 22%, 51%, and 142%, respectively, within two weeks. These levels were maintained throughout the remainder of the study.

Duration

8 weeks

Dose

100 mg
300 mg
1000 mg

Study Design

Randomized, double-blind, placebo-controlled, parallel assignment study in 140 overweight, but otherwise healthy men and women

See Published Study

Autism Spectrum Disorder

Nicotinamide Riboside Reduces Liver Fibrosis: Preclinical Findings

Synopsis Liver fibrosis is part of the non-alcoholic fatty liver disease (NAFLD) spectrum, which currently has no approved pharmacological treatment. Researchers tested whether nicotinamide ribosi...

Cardiovascular Health

Nicotinamide Riboside Protects the Heart from the Cardiotoxic Effects of Doxorubicin, a Chemotherapy Drug: Preclinical Findings

Synopsis Doxorubicin (DOX) is a common chemotherapy drug, but it can seriously damage the heart, partly due to oxidative stress. Normally, heart cells use autophagy to remove damaged components an...